Bide Pharmatech Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 26.70% vs -1.49% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 44.69% vs 9.97% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "351.60",
          "val2": "277.50",
          "chgp": "26.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "57.70",
          "val2": "46.30",
          "chgp": "24.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "0.80",
          "chgp": "37.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "1.60",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "46.30",
          "val2": "32.00",
          "chgp": "44.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "164.10%",
          "val2": "127.60%",
          "chgp": "3.65%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 1.07% vs 30.94% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 8.30% vs -25.75% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,098.30",
          "val2": "1,086.70",
          "chgp": "1.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "154.20",
          "val2": "139.70",
          "chgp": "10.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.30",
          "val2": "4.40",
          "chgp": "20.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.50",
          "val2": "-13.00",
          "chgp": "126.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "117.40",
          "val2": "108.40",
          "chgp": "8.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "100.70%",
          "val2": "90.70%",
          "chgp": "1.00%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

351.60

277.50

26.70%

Operating Profit (PBDIT) excl Other Income

57.70

46.30

24.62%

Interest

1.10

0.80

37.50%

Exceptional Items

0.00

1.60

-100.00%

Consolidate Net Profit

46.30

32.00

44.69%

Operating Profit Margin (Excl OI)

164.10%

127.60%

3.65%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 26.70% vs -1.49% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 44.69% vs 9.97% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,098.30

1,086.70

1.07%

Operating Profit (PBDIT) excl Other Income

154.20

139.70

10.38%

Interest

5.30

4.40

20.45%

Exceptional Items

3.50

-13.00

126.92%

Consolidate Net Profit

117.40

108.40

8.30%

Operating Profit Margin (Excl OI)

100.70%

90.70%

1.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 1.07% vs 30.94% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 8.30% vs -25.75% in Dec 2023

All Annual Results